Oxford, United Kingdom

Sarah Parish

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Isis Innovation Limited. Active years: 2013-2018.

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sarah Parish: Innovator in Diagnostic Methods

Introduction

Sarah Parish is a notable inventor based in Oxford, GB. She has made significant contributions to the field of diagnostic methods, particularly in understanding statin-induced myopathy. With a total of 2 patents, her work has the potential to impact the medical community significantly.

Latest Patents

One of her latest patents involves a method for determining an individual's susceptibility to statin-induced myopathy. This invention focuses on detecting the presence or absence of polymorphisms in the SLCO1B1 gene from a biological sample. The presence of these polymorphisms indicates that the individual may have an altered susceptibility to this condition. This innovative approach could lead to more personalized treatment options for patients.

Career Highlights

Throughout her career, Sarah has worked with prominent organizations such as Isis Innovation Limited and Oxford University Innovation Limited. These experiences have allowed her to develop her skills and contribute to groundbreaking research in her field.

Collaborations

Sarah has collaborated with notable individuals, including Emma Link and Rory Collins. These partnerships have further enriched her work and expanded the impact of her inventions.

Conclusion

In summary, Sarah Parish is a distinguished inventor whose work in diagnostic methods is paving the way for advancements in understanding statin-induced myopathy. Her contributions are invaluable to the medical field and highlight the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…